Mahinay, Eunna Pearl G.

HRN: 23-61-03  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/26/2023
CEFUROXIME 750MG (VIAL)
08/26/2023
09/02/2023
IV
200mg
Q8
PCAP
Checking Final Appropriateness 

Indication:  ProphylaxisEmpiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: